High-dose almitrine bismesylate inhibits hypoxic pulmonary vasoconstriction in closed-chest dogs. 1987

L Chen, and F L Miller, and G Malmkvist, and F X Clergue, and C Marshall, and B E Marshall
McNeil Center for Research in Anesthesia, University of Pennsylvania School of Medicine, Philadelphia 19104.

The effect of almitrine bismesylate on the hypoxic pulmonary vasoconstrictor (HPV) response was studied in seven closed-chest dogs anesthetized with pentobarbital and paralyzed with pancuronium. The right lung was ventilated continuously with 100% O2, while the left lung was ventilated with either 100% O2 ("hyperoxia") or with an hypoxic gas mixture ("hypoxia": end-tidal PO2 = 50.1 +/- 0.1 mmHg). Cardiac output (CO) was altered from a "normal" value of 3.10 +/- 0.18 l . min-1 to a "high" value of 3.92 +/- 0.16 l . min-1 by opening arteriovenous fistulae which allowed measurements of two points along a pressure-flow line. These four phases of left lung hypoxia or hyperoxia with normal and high cardiac output were repeated in the presence and absence of almitrine. Almitrine bismesylate was administered as a constant infusion of 14.3 micrograms . kg-1 . min-1 for a mean plasma concentration of 219.5 +/- 26.4 ng . ml-1. Relative blood flow to each lung was measured with a differential CO2 excretion (VCO2) method corrected for the Haldane effect. With both lungs hyperoxic, the percent left lung blood flow (%QL-VCO2) was 44 +/- 1%. When the left lung was exposed to hypoxia, the %QL-VCO2 decreased significantly to 22 +/- 1%. However, with the administration of almitrine, the %QL-VCO2 during left lung hypoxia increased significantly to 36 +/- 2%. The arterial oxygen tension decreased significantly between hyperoxia (PaO2 = 633 +/- 6 mmHg) and hypoxia (271 +/- 31 mmHg). With the addition of almitrine, there was no change during hyperoxia; however, during hypoxia, the PaO2 decreased significantly to 124 +/- 15 mmHg. Cardiac output did not influence these findings. The pulmonary vascular conductance (G) is the slope of the pressure-flow line.(ABSTRACT TRUNCATED AT 250 WORDS)

UI MeSH Term Description Entries
D008168 Lung Either of the pair of organs occupying the cavity of the thorax that effect the aeration of the blood. Lungs
D010879 Piperazines Compounds that are derived from PIPERAZINE.
D004285 Dogs The domestic dog, Canis familiaris, comprising about 400 breeds, of the carnivore family CANIDAE. They are worldwide in distribution and live in association with people. (Walker's Mammals of the World, 5th ed, p1065) Canis familiaris,Dog
D005260 Female Females
D000697 Central Nervous System Stimulants A loosely defined group of drugs that tend to increase behavioral alertness, agitation, or excitation. They work by a variety of mechanisms, but usually not by direct excitation of neurons. The many drugs that have such actions as side effects to their main therapeutic use are not included here. Analeptic,Analeptic Agent,Analeptic Drug,Analeptics,CNS Stimulant,CNS Stimulants,Central Nervous System Stimulant,Central Stimulant,Analeptic Agents,Analeptic Drugs,Central Stimulants,Agent, Analeptic,Agents, Analeptic,Drug, Analeptic,Drugs, Analeptic,Stimulant, CNS,Stimulant, Central,Stimulants, CNS,Stimulants, Central
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000860 Hypoxia Sub-optimal OXYGEN levels in the ambient air of living organisms. Anoxia,Oxygen Deficiency,Anoxemia,Deficiency, Oxygen,Hypoxemia,Deficiencies, Oxygen,Oxygen Deficiencies
D014661 Vasoconstriction The physiological narrowing of BLOOD VESSELS by contraction of the VASCULAR SMOOTH MUSCLE. Vasoconstrictions
D015765 Almitrine A respiratory stimulant that enhances respiration by acting as an agonist of peripheral chemoreceptors located on the carotid bodies. The drug increases arterial oxygen tension while decreasing arterial carbon dioxide tension in patients with chronic obstructive pulmonary disease. It may also prove useful in the treatment of nocturnal oxygen desaturation without impairing the quality of sleep. Almitrine Bismesylate,Almitrine Bis(methanesulfonate),Almitrine Dimesylate,Almitrine Monomesylate,Vectarion,Monomesylate, Almitrine

Related Publications

L Chen, and F L Miller, and G Malmkvist, and F X Clergue, and C Marshall, and B E Marshall
January 1989, The American review of respiratory disease,
L Chen, and F L Miller, and G Malmkvist, and F X Clergue, and C Marshall, and B E Marshall
February 1989, The Tohoku journal of experimental medicine,
L Chen, and F L Miller, and G Malmkvist, and F X Clergue, and C Marshall, and B E Marshall
April 1991, Journal of applied physiology (Bethesda, Md. : 1985),
L Chen, and F L Miller, and G Malmkvist, and F X Clergue, and C Marshall, and B E Marshall
January 1990, Thorax,
L Chen, and F L Miller, and G Malmkvist, and F X Clergue, and C Marshall, and B E Marshall
August 1983, The American review of respiratory disease,
L Chen, and F L Miller, and G Malmkvist, and F X Clergue, and C Marshall, and B E Marshall
March 1993, Medicina clinica,
L Chen, and F L Miller, and G Malmkvist, and F X Clergue, and C Marshall, and B E Marshall
July 1989, Critical care medicine,
L Chen, and F L Miller, and G Malmkvist, and F X Clergue, and C Marshall, and B E Marshall
August 1992, The American journal of physiology,
L Chen, and F L Miller, and G Malmkvist, and F X Clergue, and C Marshall, and B E Marshall
August 2004, Journal of applied physiology (Bethesda, Md. : 1985),
L Chen, and F L Miller, and G Malmkvist, and F X Clergue, and C Marshall, and B E Marshall
January 1987, Masui. The Japanese journal of anesthesiology,
Copied contents to your clipboard!